Physician

Agustin Pimentel

According to 2025 Medicare claims, Agustin Pimentel (NPI: 1740498146) practices hematology/oncology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1922058544; TIN: 592579938) and primary practice location at 33136-1002.

Pimentel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 582 HCPCS/CPT codes, and received $37,973 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 509 prescription claims across 105 beneficiaries totaling $1,478,557 in drug costs, led by Lonsurf (Trifluridine/Tipiracil Hcl). 2023 DME data shows 174 claims. Open Payments data shows 3 records totaling $15,232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $209,011 to $1,478,557. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,238 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	212	635	$49,890
2016	230	690	$56,439
2017	199	581	$48,439
2018	219	662	$55,324
2019	195	558	$44,774
2020	166	502	$39,637
2021	174	493	$50,024
2022	182	511	$51,045
2023	148	440	$45,313
2024	139	582	$37,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	363	$209,011
2016	78	488	$322,026
2017	72	397	$542,201
2018	80	411	$462,089
2019	75	302	$485,916
2020	61	229	$960,156
2021	61	204	$647,848
2022	78	242	$775,815
2023	89	514	$1,136,870
2024	105	509	$1,478,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$2,078
2016	23	97	$54,829
2017	N/R	54	$14,997
2018	N/R	N/R	N/R
2019	N/R	11	$2,835
2020	N/R	28	$2,934
2021	28	58	$4,678
2022	13	244	$89,602
2023	N/R	174	$91,367
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	155	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	152	$77
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	13	14	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	18	19	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	98	190	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lonsurf	Trifluridine/Tipiracil Hcl	33	924	$567,737
Stivarga	Regorafenib	11	308	$128,612
Creon	Lipase/Protease/Amylase	25	791	$65,700
Eliquis	Apixaban	23	690	$13,499
Xarelto	Rivaroxaban	12	660	$12,067

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$99	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$15,133	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Agustin Pimentel?

Tedicare shows public-source Medicare data for Agustin Pimentel (NPI 1740498146), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Agustin Pimentel have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Agustin Pimentel?

Agustin Pimentel is linked to UNIVERSITY OF MIAMI (billing NPI 1922058544) in the available physician profile data.

Does Agustin Pimentel have Open Payments data?

Agustin Pimentel has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.